Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Depreciation & Amortization (CF) (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $746211.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) fell 26.72% year-over-year to $746211.0, compared with a TTM value of $2.9 million through Sep 2025, down 45.78%, and an annual FY2024 reading of $3.8 million, down 68.98% over the prior year.
  • Depreciation & Amortization (CF) was $746211.0 for Q3 2025 at SBC Medical Group Holdings, up from $636101.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $2.6 million in Q4 2023 and bottomed at $628304.0 in Q1 2025.
  • Average Depreciation & Amortization (CF) over 3 years is $1.1 million, with a median of $931596.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) crashed 63.59% in 2024, then dropped 23.45% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $2.6 million in 2023, then plummeted by 63.59% to $931596.0 in 2024, then dropped by 19.9% to $746211.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SBC at $746211.0 in Q3 2025, $636101.0 in Q2 2025, and $628304.0 in Q1 2025.